Despite MannKind's share price surge, its P/S ratio is low due to a bleak revenue outlook. Shareholders accept this, anticipating no future revenue surprises. A turn of luck is needed for a higher P/S.
Analysts' forecasts reveal that MannKind Corporation's inferior revenue outlook is contributing to its lower P/S ratio. Shareholders accept this, cognizant that future revenue may not meet expectations, hence posing a hindrance for the share price at these levels.
MannKind's progress is recognized by the market and worth investor examination. However, two warning signs warrant attention. Strong share price momentum suggests opportunity.
マンカインドに関するコメント
need to find out more
In reaction to earnings/guidance:
• $ユナイテッド・マイクロエレクトロニクス(UMC.US)$ +0.8% (August revs)
Other news:
• $ChannelAdvisor(ECOM.US)$ +54.4% (to be acquired for $23.10 per share)
• $IVERIC bio(ISEE.US)$ +42.3% (topline data from Zimura GATHER2 phase 3 clinical trialingeographic atrophy)
• $モンテ ローザ セラピューティクス(GLUE.US)$ +10% (receives FDA clearance of Investigational New Drug Application for MRT-2359)
• $IDEAYAバイオサイエンシズ(IDYA.US)$ +4.9% (re...
• $エンフェーズ エナジー(ENPH.US)$ +8.2% (earnings reports)
• $ゼンタリス ファーマシューティカルズ(ZNTL.US)$ +7.6% (announces $25 mln equity investment from Pfizer (PFE); enters into development collaboration for ZN-c3)
• $テルニウム(TX.US)$ +6.1% (earnings reports)
• $ピュアサイクル テクノロジーズ(PCT.US)$ +5% (SEC concludes investigation without further action)
• $アライアンス・リソース・パートナーズ(ARLP.US)$ +4.7% (increases dividend; provides prelim qtrly results)
• $Digital World Acquisition Corp(DWAC.US)$ +4.5% (cu...
まだコメントはありません